Integra Lifesciences lowered its 2026 revenue guidance to $1.634-$1.654 billion and adjusted earnings per share to $2.30-$2.40 due to flooding disruptions at its Cincinnati facility. The flood reduced third-quarter revenue by about $7 million and is expected to impact the fourth quarter by $15-$20 million. Despite this, the company expects strong cash flow and full manufacturing operations to resume by mid-2027, supported by insurance recoveries and improved product availability. Shares dropped 20.6% following the announcement.
Integra LifeSciences' revised 2026 outlook is presented here with Pluang's Health sector data as of Oct 02, 2026 22:11 WIB. Of 100 priced Health-sector US stocks tradable on Pluang, 39 rose and 59 fell today. Notable movers include BNGO at USD 1.50 with a 4.78% decline and a typical hold time of 49 days, TXG at USD 92.50 rising 4.21% with 90% buy order activity, and ACHC at USD 27.96 up 3.82% but with 100% sell order activity.
NextEra Energy and partners are developing Project Star, a $22.3 billion natural gas-powered energy campus in Encinal, Texas, aimed at powering a large data center and supplying the grid. The campus will have 6.47 gigawatts of generation capacity, wi...
UBS has increased its price target for G-III Apparel Group to $27.00 from $26.00, reflecting confidence in the company's financial health and market position. Although the current share price slightly exceeds UBS's target, other analysts see potentia...
Enerflex secured a contract to build about 450 megawatts of natural gas-fired power units for a North American data center developer, with deliveries starting in 2027 and completing in 2028. The company’s 2026 capital spending includes $15 million fo...
UBS lowered its price target for McCormick from $52 to $48 following the company's Q3 fiscal 2026 results. Although McCormick beat expectations and confirmed its full-year outlook, its net income fell sharply to $97.6 million from $225.5 million year...
TransUnion has announced that its VantageScore 4.0 mortgage scores will be priced at $0.99 each until December 2028, providing stable and predictable costs for lenders. This pricing strategy follows the Federal Housing Finance Agency's decision to ex...
